Abstract
As the long-term survival of nonrenal solid-organ transplant recipients continues to improve, more complications related to transplantation occur. Among the most serious is chronic kidney disease (CKD). Although CKD was previously thought to only clinically affect a minority of this population, closer measurements of kidney function and monitoring of CKD complications now show that CKD will affect a significant number, if not a majority, of transplant recipients-particularly the long-term survivors who often have excellent function of their primary allograft. This article will review the incidence, risk factors, treatment, and outcomes of patients who develop CKD after heart, liver, and lung transplantation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
